Plaintiffs Can Introduce New Expert In Zoloft MDL, Judge Says

Law360, New York (January 8, 2015, 7:55 PM EST) -- A Pennsylvania federal judge on Thursday allowed plaintiffs in multidistrict litigation over Pfizer Inc. antidepressant Zoloft's alleged birth defect risks to introduce a new causation expert after the court excluded the testimonies of four previous experts they had brought in.

U.S. District Judge Cynthia Rufe ruled that plaintiffs can introduce Nicholas Jewell, a professor at the University of California, Berkeley's School of Public Health and its statistics department, as a general causation expert. Judge Rufe found that the evidence Jewell is expected to introduce — on the alleged heart health risks posed by Zoloft — is of "critical importance" to the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!